# US 2016/0256115 A1 · Methods and Systems for Predicting Patient Responsiveness to Subcutaneous Neuromodulation Therapy as a Treatment for Hypertension

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0256115 A1
- Document ID: US20160256115A1
- Status: Published application
- Kind: A1
- Application number: 15/057,106
- Filed: 2016-02-29
- Published: 2016-09-08
- Earliest claimed: 2015-03-02
- Assignees: Valencia Technologies Corporation
- Applicants: Valencia Technologies Corporation
- Inventors: David K. L. Peterson
- Web page: https://patentgrep.com/patent/US20160256115A1

## CPC

- A61B 5/7275: {Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor}
- A61B 5/021: Measuring pressure in heart or blood vessels
- A61B 5/7246: {using correlation, e.g. template matching or determination of similarity}
- A61N 1/0504: {Subcutaneous electrodes}
- A61N 1/36117: {for treating hypertension}
- G16H 20/40: relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture
- G16H 50/30: for calculating health indices; for individual health risk assessment
- G16H 20/10: relating to drugs or medications, e.g. for ensuring correct administration to patients
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA

## Abstract

An exemplary method includes determining a variability of a plurality of measurements of a cardiovascular parameter of a patient suffering from hypertension, the plurality of measurements recorded one at a time over a predetermined time period. The method further includes comparing the determined variability with a predetermined reference value. If the comparing indicates that the determined variability is less than the predetermined reference value, the method includes designating the patient to be within a first class of patients representative of patients that are likely to be responsive to subcutaneous neuromodulation therapy as a treatment for hypertension. If the comparing indicates that the determined variability is greater than the predetermined reference value, the method includes designating the patient to be within a second class of patients representative of patients that are likely to be unresponsive to subcutaneous neuromodulation therapy as a treatment for hypertension. Corresponding systems and methods are also described.

## Claims

### Claim 1

A method comprising:
determining, by a therapy response prediction system, a variability of a plurality of measurements of a cardiovascular parameter of a patient suffering from hypertension, the plurality of measurements recorded one at a time over a predetermined time period;
comparing, by the therapy response prediction system, the determined variability with a predetermined reference value;
designating, by the therapy response prediction system if the comparing indicates that the determined variability is less than the predetermined reference value, the patient to be within a first class of patients, the first class of patients representative of patients that are likely to be responsive to subcutaneous neuromodulation therapy as a treatment for hypertension; and
designating, by the therapy response prediction system if the comparing indicates that the determined variability is greater than the predetermined reference value, the patient to be within a second class of patients, the second class of patients representative of patients that are likely to be unresponsive to subcutaneous neuromodulation therapy as a treatment for hypertension.

### Claim 2 (depends on 1)

The method of claim 1, wherein the predetermined time period corresponds to waking hours of the patient during a single day.

### Claim 3 (depends on 2)

The method of claim 2, wherein at least some of the plurality of measurements are recorded at scheduled times occurring at least twice per hour during the waking hours of the patient.

### Claim 4 (depends on 1)

The method of claim 1, wherein the predetermined time period includes twenty-four consecutive hours.

### Claim 5 (depends on 4)

The method of claim 4, wherein:
at least some of the plurality of measurements are recorded at scheduled times occurring at least twice per hour during waking hours of the patient within the twenty-four consecutive hours; and
at least some of the plurality of measurements are recorded at scheduled times occurring at least once per hour during sleeping hours of the patient within the twenty-four consecutive hours.

### Claim 6 (depends on 1)

The method of claim 1, wherein the cardiovascular parameter of the patient is at least one of a systolic blood pressure and a diastolic blood pressure of the patient.

### Claim 7 (depends on 1)

The method of claim 1, wherein:
the variability of the plurality of measurements is a standard deviation of the plurality of measurements of the cardiovascular parameter of the patient; and
the predetermined reference value represents a reference standard deviation.

### Claim 8 (depends on 1)

The method of claim 1, wherein:
the variability of the plurality of measurements is an index of variability value calculated by dividing a standard deviation of the plurality of measurements of the cardiovascular parameter of the patient by a square root of an average cardiovascular parameter of the patient, the average cardiovascular parameter of the patient generated by averaging, over the predetermined time period, the plurality of measurements of the cardiovascular parameter of the patient; and
the predetermined reference value represents a reference index of variability calculated by dividing a reference standard deviation by a square root of a group-averaged cardiovascular parameter, the group-averaged cardiovascular parameter generated by averaging a plurality of average cardiovascular parameters of members of a group including a plurality of other patients suffering from hypertension.

### Claim 9 (depends on 1)

The method of claim 1, wherein the determining of the variability of the plurality of measurements of the cardiovascular parameter of the patient includes receiving a value representative of the variability from a measuring device separate from the therapy response prediction system, wherein the measuring device is configured to record the plurality of measurements of the cardiovascular parameter of the patient and calculate the value of the variability.

### Claim 10 (depends on 1)

The method of claim 1, wherein the determining of the variability of the plurality of measurements of the cardiovascular parameter of the patient includes:
receiving, from a measuring device separate from the therapy response prediction system and configured to record the plurality of measurements, data representative of the plurality of measurements; and
using the data representative of the plurality of measurements to calculate a value representative of the variability.

### Claim 11 (depends on 1)

The method of claim 1, wherein the determining of the variability of the plurality of measurements of the cardiovascular parameter of the patient includes normalizing a value representative of the variability to account for a bias of a measuring device separate from the therapy response prediction system and used to record the plurality of measurements of the cardiovascular parameter of the patient.

### Claim 12 (depends on 1)

The method of claim 1, wherein:
the designating of the patient to be within the first class of patients includes assigning, within a storage facility of the therapy response prediction system, the patient a first binary value representative of a determination by the therapy response prediction system that the patient is likely to be responsive to the subcutaneous neuromodulation therapy as a treatment for hypertension; and
the designating of the patient to be within the second class of patients includes assigning, within the storage facility of the therapy response prediction system, the patient a second binary value different than the first binary value and representative of a determination by the therapy response prediction system that the patient is likely to be unresponsive to the subcutaneous neuromodulation therapy as a treatment for hypertension.

### Claim 13 (depends on 1)

The method of claim 1, further comprising:
providing, by the therapy response prediction system for use by a user of the therapy response prediction system, a graphical user interface presented on a display screen associated with the therapy response prediction system;
presenting, by the therapy response prediction system within the graphical user interface if the patient is designated to be within the first class of patients, an indication that the patient is likely to be responsive to the subcutaneous neuromodulation therapy as a treatment for hypertension; and
presenting, by the therapy response prediction system within the graphical user interface if the patient is designated to be within the second class of patients, an indication that the patient is likely to be unresponsive to the subcutaneous neuromodulation therapy as a treatment for hypertension.

### Claim 14 (depends on 1)

The method of claim 1, further comprising:
automatically enabling, by the therapy response prediction system if the patient is designated to be within the first class of patients, a disabled subcutaneous neuromodulation therapy device implanted within the patient as treatment for the hypertension of the patient; and
avoiding enabling, by the therapy response prediction system if the patient is designated to be within the second class of patients, the disabled subcutaneous neuromodulation therapy device implanted within the patient as treatment for the hypertension of the patient.

### Claim 15 (depends on 1)

The method of claim 1, embodied as computer-executable instructions on at least one non-transitory computer-readable medium.

### Claim 16

A method comprising:
determining, by a therapy response prediction system, an index of variability of a plurality of blood pressure measurements of a patient suffering from hypertension, the plurality of blood pressure measurements recorded one at a time during waking hours of the patient during a single day, and the index of variability calculated by dividing a standard deviation of the plurality of blood pressure measurements of the patient by a square root of an average blood pressure parameter of the patient generated by averaging, over the waking hours during the single day, the plurality of blood pressure measurements of the patient;
comparing, by the therapy response prediction system, the determined index of variability with a predetermined reference index of variability calculated by dividing a reference standard deviation by a square root of a group-averaged blood pressure parameter, the group-averaged blood pressure parameter generated by averaging a plurality of average blood pressure parameters of members of a group including a plurality of other patients suffering from hypertension;
designating, by the therapy response prediction system if the comparing indicates that the determined index of variability is less than the predetermined reference index of variability, the patient to be within a first class of patients, the first class of patients composed of patients that are likely to be responsive to subcutaneous neuromodulation therapy as a treatment for hypertension; and
designating, by the therapy response prediction system if the comparing indicates that the determined index of variability is greater than the predetermined reference index of variability, the patient to be within a second class of patients, the second class of patients composed of patients that are likely to be unresponsive to subcutaneous neuromodulation therapy as a treatment for hypertension.

### Claim 17 (depends on 16)

The method of claim 16, embodied as computer-executable instructions on at least one non-transitory computer-readable medium.

### Claim 18

A system comprising:
at least one physical computing device that:
determines a variability of a plurality of measurements of a cardiovascular parameter of a patient suffering from hypertension, the plurality of measurements recorded one at a time over a predetermined time period;
compares the determined variability with a predetermined reference value;
designates, if the comparison indicates that the determined variability is less than the predetermined reference value, the patient to be within a first class of patients, the first class of patients representative of patients that are likely to be responsive to subcutaneous neuromodulation therapy as a treatment for hypertension; and
designates, if the comparison indicates that the determined variability is greater than the predetermined reference value, the patient to be within a second class of patients, the second class of patients representative of patients that are likely to be unresponsive to subcutaneous neuromodulation therapy as a treatment for hypertension.

### Claim 19 (depends on 18)

The system of claim 18, wherein:
the variability of the plurality of measurements is a standard deviation of the plurality of measurements of the cardiovascular parameter of the patient; and
the predetermined reference value represents a reference standard deviation.

### Claim 20 (depends on 18)

The system of claim 18, wherein:
the variability of the plurality of measurements is an index of variability value calculated by dividing a standard deviation of the plurality of measurements of the cardiovascular parameter of the patient by a square root of an average cardiovascular parameter of the patient, the average cardiovascular parameter of the patient generated by averaging, over the predetermined time period, the plurality of measurements of the cardiovascular parameter of the patient; and
the predetermined reference value represents a reference index of variability calculated by dividing a reference standard deviation by a square root of a group-averaged cardiovascular parameter, the group-averaged cardiovascular parameter generated by averaging a plurality of average cardiovascular parameters of members of a group including a plurality of other patients suffering from hypertension.
